Heterobicyclic compounds
Heterobicyclic compounds of Formula (I):or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.
Amgen Inc.
C A C C C C A A C C C C C A A
C07D A61P C07D C07D C07D C07D A61P A61P C07D C07D C07D C07D C07D A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Thomas T. Jennifer R. Alexander J. Chester Chenguang Jian J. Albert Kristin L. James Ning Wenge Wenyuan Essa Hu Qingyian Robert M. Shannon
Nguyen Allen Pickrell Yuan Chen Amegadzie Andrews Brown Chen Zhong Qian Harrington Liu Rzasa Rumfelt